Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0980120190170020046
Annals of Phlebology
2019 Volume.17 No. 2 p.46 ~ p.49
Non-Vitamin K Antagonist Oral Anticoagulants for High Risk Patients, CRF, Elderly, Bleeding in Venous Thromboembolic Disease
Kwon Su-Kyung

Kim Hyang-Kyoung
Abstract
Non-vitamin K antagonist oral anticoagulants (NOACs) are widely accepted for the treatment of venous thromboembolic disease as an alternative to vitamin K antagonists. However, still clear answer was not given regarding the safe use of NOAC in specific clinical situations. We purposed to review the optimal use of NOAC in fragile patients, including patients with chronic kidney disease, advanced age or bleeding.
KEYWORD
Non-vitamin K antagonist oral anticoagulants, Venous thromboembolic disease, Chronic kidney disease, Old age, Bleeding risk
FullTexts / Linksout information
Listed journal information